ArticleNeurobiology of disease2014

Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging.

Francesco Longo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.